McKay Filters Through Frontline Treatment Considerations in mRCC

Season 5 Episode 39  ·  Sep 06, 2021, 07:00 PM

Headliner
Share
Subscribe

Dr. McKay discusses the importance of patient selection in advanced renal cell carcinoma, selecting between available combination regimens, and nuances regarding the timing of treatment in this disease.

Share
Subscribe
Next
Lisberg Discusses the Promise of Datapotamab Deruxtecan in Lung Cancer
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air